A series of blood tests was nearly as accurate at predicting the progression of liver damage as liver biopsies in people coinfected with both HIV and hepatitis C virus (HCV), say the authors of a study published in the July 31 issue of AIDS. The high level of accuracy, the authors conclude, may reduce the number of liver biopsies in coinfected patients by 83 percent.